[bannerheader title=”About Us” subtitle=”Our Team”]
Visionary and Pioneering Scientific Leaders
[management name=”Dr. Camie Chan” position=”CEO” description=”
- A seasoned scientist and biotech executive
- With a B.S. (Hons) in Biotech from University of Waterloo, M.Sc. in Medical Sciences and PhD in Immunology from University of Toronto,
- Postdoctoral training at Sydney Kimmel Cancer Research Center at Johns Hopkins on a prestigious NIH fellowship award. Subsequently, she became Assistant Professor at University of California, Davis, Deputy Director of the Faculty of Medicine Core Facility & Assistant Professor of Anatomy at the University of Hong Kong
- Specializes in various aspects of human transplantation and immunology with particular interests in the use of DC, NK, T cells, etc. for immunotherapy against cancer
- Numerous awards include the National Institute of Allergy and Infectious Diseases (NIAID) Developmental Research Grant from NIH
- Spearheading to launch and design the cGMP facility, and establish the existing partnerships and various projects such as CAR-T and Haplobank
” image=”https://www.xelleratherapeutics.com/wp-content/uploads/2022/02/Camie-Chan.jpg”]
[management name=”Dr. Katherine Ngan” position=”Chairperson” description=”
- President, May Cheong Group.
- Honorary Doctorate of Business Administration from the Hong Kong Polytechnic University.
- Honorary President, The Chinese Manufacturers’ Association of HK.
- Winner of the GBA Outstanding Women Entrepreneur Award – Supreme Honorable Winner 2021 Winner 2021
” image=”https://www.xelleratherapeutics.com/wp-content/uploads/2022/02/Katherine-Ngan.jpg”]
[management name=”Mr. Allen Ma” position=”Co-chair” description=”
- Former CEO of Hong Kong Science & Technology Parks
- President for APAC at British Telecom
- VP for Asian markets Global Telecom Solutions Sector at Motorola
- Executive Director at Cable & Wireless Hong Kong Telecom
- MD of CSL. MBA (Toronto); Fellow members
- CIMA(UK) and ACCA(UK); CPA, CMA in Canada
” image=”https://www.xelleratherapeutics.com/wp-content/uploads/2022/06/Screenshot-2022-06-08-at-4.59.33-PM.png”]
[management name=”Prof. Paul Tam” position=”Vice-chair & Scientific Co-founder” description=”
- Specialist in Paediatric Surgery, Hong Kong Sanatorium & Hospital.
- Past Provost and Deputy Vice-Chancellor, Former Acting President and Vice-Chancellor, The University of Hong Kong.
- Vice President, Macau University of Science and Technology.
” image=”https://www.xelleratherapeutics.com/wp-content/uploads/2022/02/Paul-Tam.jpg”]
[management name=”Prof. Godfrey Chan” position=”CMO & Scientific Co-founder” description=”
- Specialist in Paediatric Haematology & Oncology, Hong Kong Sanatorium & Hospital.
- Chief of Service at the Hong Kong Children’s Hospital, and Former Head of Department of Paediatrics and Adolescent Medicine at the University of Hong Kong.
- Honorary Clinical Professor, Department of Paediatrics and Adolescent Medicine, The University of Hong Kong.
- Clinical expert in childhood cancer and haematopoietic stem cell transplantation. His research focus is on cancer immunology and mesenchymal stem cells biology.
- Multiple International Awards (ANR, SIOP, ASPR, Endeavor Executive Award-Australian Government, and Outstanding Pediatrician of APPA) for his clinical and laboratory research works on childhood neurogenic tumors and stem cells biology.
” image=”https://www.xelleratherapeutics.com/wp-content/uploads/2022/02/Godfrey-Chan.jpg”]
[management name=”Prof. Ronald Li” position=”Founder” description=”
- An internationally recognized expert in cardiac electrophysiology, human heart cell & tissue engineering and pluripotent stem cells.
- CEO and Co-founder of Medera Biopharmaceutical.
- Served as Assistant, Associate and Full Professor at Johns Hopkins University, University of California, Davis and Icahn School of Medicine at Mount Sinai in New York.
- Founding Director of the Stem Cell & Regenerative Medicine Consortium at the University of Hong Kong.
- Former Director of Ming-Wai Lau Centre for Reparative Medicine, Karolinska Institutet (KI), HK/Sweden.
” image=”https://www.xelleratherapeutics.com/wp-content/uploads/2022/02/Ronald-Li.jpg”]
[management name=”Prof. Marc Turner” position=”Chair of Scientific Advisory Board” description=”
- Medical Director, Scottish National Blood Transfusion Service.
- Board Chair, Global Alliance of iPSC Therapies (GAiT)
” image=”https://www.xelleratherapeutics.com/wp-content/uploads/2022/02/Marc-Mercola.jpg”]